Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search Results for: theranos lawsuits

Might Lawsuits Come Next in the Theranos Story?

TDR Insider / By Mary Van Doren

Tailored to the needs and interests of lab administrators and pathologists, THE DARK REPORT provides new insights into the continuing saga of Theranos. A stream of headline stories in recent weeks has painted the controversial lab testing company in an uncomplimentary way, and TDR puts you front and center in these important developments. Have you been …

Might Lawsuits Come Next in the Theranos Story? Read More »

To access this post, you must purchase The Dark Report.

Might Lawsuits Come Next in Theranos Story?

Clinical Laboratory / By Robert Michel

CEO SUMMARY: Recent disclosures in the news indicate that an agreement between Theranos and Safeway has gone sour— after Safeway spent a third of a billion dollars to fulfill its part of the collaboration! Reporting by The Wall Street Journal claimed that Theranos and Safeway are negotiating over this situation. If the two parties cannot …

Might Lawsuits Come Next in Theranos Story? Read More »

To access this post, you must purchase The Dark Report.

Theranos Lays Off More Staff, Voids More Lab Test Results

Clinical Laboratory / By Joseph Burns

ONCE AGAIN, the controversial lab testing company, Theranos, Inc., found itself the subject of negative news stories. In recent weeks, The Wall Street Journal reported that the beleaguered lab testing company in Palo Alto, Calif., laid off 155 staffers, voided more laboratory test results, and cut ties with its high-profile lawyer. This round of bad …

Theranos Lays Off More Staff, Voids More Lab Test Results Read More »

To access this post, you must purchase The Dark Report.

Theranos Ends Patient Testing, Sued for Deceiving Investors

Clinical Laboratory / By Joseph Burns

IN THE EARLY 1960S, the great bluesman Albert King wrote, “Born Under a Bad Sign,” which contained the unforgettable lyric, “If it wasn’t for bad luck, I wouldn’t have no luck at all.” That lyric almost describes what’s happened to Theranos Inc. since October 2015. Although some would argue that Theranos brought this misfortune upon itself, …

Theranos Ends Patient Testing, Sued for Deceiving Investors Read More »

To access this post, you must purchase The Dark Report.

Walgreens Tells Theranos: ‘Lab Deal Is Terminated’

Laboratory Compliance / By Robert Michel

BREAKING NEWS: As this issue of THE DARK REPORT went to press, it was learned that Walgreens had announced the termination of its lab testing agreement with Theranos, effective immediately. Theranos loses access to about 40 Walgreens pharmacies in Phoenix and is left with about five patient collection centers. The following story summarizes developments involving …

Walgreens Tells Theranos: ‘Lab Deal Is Terminated’ Read More »

To access this post, you must purchase The Dark Report.

Up to 30,000 Theranos test results voided; Walgreen dumps partnership

TDR Insider / By Mary Van Doren

This is an excerpt from a 1,000-word article in the June 13 issue of THE DARK REPORT. The original article is available to paid members of the Dark Intelligence Group. EXECUTIVE SUMMARY: The disruptor’s plans have been thoroughly disrupted. As this issue of THE DARK REPORT went to press, it was learned that Walgreens had announced …

Up to 30,000 Theranos test results voided; Walgreen dumps partnership Read More »

To access this post, you must purchase The Dark Report.

Washington Post: Theranos Approached Military in 2012

Clinical Laboratory / By Joseph Burns

SINCE THE WALL STREET JOURNAL published its exposé of Theranos Inc. in October, other media outlets have published the findings of their own investigations into various aspects of the lab company’s practices. One example is the disclosure by The Wall Street Journal in November that Theranos had an agreement with Safeway to put blood collection …

Washington Post: Theranos Approached Military in 2012 Read More »

To access this post, you must purchase The Dark Report.

CLIA Lab Director Testimony Shows Risks to Pathologists

Laboratory Compliance / By Robert Michel

CEO SUMMARY: Elizabeth Holmes’ criminal trial is a case study for clinical lab directors in how not to run a medical lab, according to an attorney with 30 years of advising labs on CLIA-enforcement issues. During the trial, federal prosecutors cited the Clinical Laboratory Improvement Amendments multiple times. In each instance, the DOJ has presented …

CLIA Lab Director Testimony Shows Risks to Pathologists Read More »

To access this post, you must purchase The Dark Report.

Several Big Surprises in 2018’s Top 10 Lab Stories

Laboratory Management / By Robert Michel

CEO SUMMARY: This year’s list of the Top 10 Lab Industry Stories for 2018 is dominated by new directives from Medicare and private health insurers, as well as significant decisions by federal courts. Collectively, these developments create new compliance risks for all clinical laboratories and anatomic pathology groups. What is more notable about these top …

Several Big Surprises in 2018’s Top 10 Lab Stories Read More »

To access this post, you must purchase The Dark Report.

Discovery of Pathology Errors Shows Quality Flaws

Commentary and Opinion by R. Lewis Dark / By R. Lewis Dark

MOST PATHOLOGISTS WOULD AGREE THAT PATIENTS AND THEIR PHYSICIANS have every right to expect a timely, accurate lab test result. Stated differently, patients and physicians implicitly trust that a pathology laboratory in the United States will not make errors in specimen processing (technical component) and diagnosis (professional component). For these reasons, the recent federal Centers …

Discovery of Pathology Errors Shows Quality Flaws Read More »

To access this post, you must purchase The Dark Report.

;